SCHEMBL20090086

SCHEMBL20090086

O=P(c1ccccc1)(c1ccc(-c2ccc(-c3ccc4c5ccc6ccccc6c5c5nc6ccccc6n5c4c3)cc2)cc1)c1ccc2ccccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
HPGD P15428 5/20 0.39
KDM4E B2RXH2 4/20 0.39
KMT2A Q03164 5/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
MAPT P10636 4/20 0.34
POLB P06746 2/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MEN1 O00255 3/20 0.34
CAMKK1 Q8N5S9 2/20 0.34
CAMKK2 Q96RR4 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CASP1 P29466 1/20 0.34
CYP2C19 P33261 1/20 0.34
CASP7 P55210 1/20 0.34
FLT3 P36888 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20090131 0.98 HPGD (0.39) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL18118576 0.97 HPGD (0.38) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL14644211 0.96 ALDH1A1 (0.41) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL20090127 0.96 ALDH1A1 (0.41) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL20090092 0.93 ALDH1A1 (0.34) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL20090223 0.93 HPGD (0.34) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL20090193 0.93 UTRN (0.32) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960051 0.93 KDM4E (0.39) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960132 0.92 KDM4E (0.37) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL20090235 0.92 HPGD (0.35) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-07-16 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 ALDH1A1 750/4885HPGD 2982/4885KDM4E 1997/4885
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 ALDH1A1 750/4885HPGD 2982/4885KDM4E 1997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.